AVNS (Avanos Medical) Accounts Payable: $52.3 Mil (As of Mar. 2026)


AVNS Avanos Medical Inc AVNS
62 GF Score
Price $24.93
GF Value $19.40
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Avanos Medical Accounts Payable?

Avanos Medical AVNS +0.02% 62 Accounts Payable is $52.3 Mil as of Mar. 2026. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.40 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Avanos Medical's Accounts Payable for the quarter that ended in Mar. 2026 was $52.3 Mil.

Avanos Medical's quarterly Accounts Payable increased from Sep. 2025 ($54.2 Mil) to Dec. 2025 ($55.5 Mil) but then declined from Dec. 2025 ($55.5 Mil) to Mar. 2026 ($52.3 Mil).

Avanos Medical's annual Accounts Payable declined from Dec. 2023 ($56.3 Mil) to Dec. 2024 ($54.3 Mil) but then increased from Dec. 2024 ($54.3 Mil) to Dec. 2025 ($55.5 Mil).

Avanos Medical Accounts Payable Related Terms

Avanos Medical Accounts Payable Historical Data

* Premium members only.

The historical data trend for Avanos Medical's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avanos Medical Accounts Payable Chart

Avanos Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.40 67.90 56.30 54.30 55.50

Avanos Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.00 48.80 54.20 55.50 52.30
AVNS
62GF Score
Avanos Medical Inc AVNS
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avanos Medical Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $52.3 Mil mean?
Avanos Medical (AVNS) has a Accounts Payable of $52.3 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Avanos Medical and its competitors.
Is Avanos Medical's Accounts Payable too high?
Avanos Medical's current Accounts Payable is $52.3 Mil. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's Accounts Payable compare to LMRI and AORT?
Avanos Medical's Accounts Payable of $52.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Avanos Medical and its competitors. Avanos Medical's current Accounts Payable is $52.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.40, compared to a current price of $24.93 — trading 28.5% above its estimated fair value. The current Accounts Payable is $52.3 Mil. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Avanos Medical (AVNS), the current Accounts Payable is $52.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Avanos Medical (AVNS) Overvalued in 2026?

Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued. The current stock price of $24.93 is trading 28.5% above its estimated GF Value™ of $19.40. GuruFocus considers Avanos Medical to be Modestly Overvalued.

Key valuation signals for AVNS:

  • Accounts Payable: $52.3 Mil
  • GF Value™: $19.40 vs. price of $24.93 (28.5% above fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Avanos Medical Business Description

Address 5405 Windward Parkway, Suite 100 South, Alpharetta, GA, USA, 30004
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score

Get the complete analysis for AVNS

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.93
Price
$19.40
GF Value